title: In-111 pentetreotide. Superior imaging agent for gastrinomas.
abstract: Gastrinomas are usually diagnosed clinically and localized before surgery using various imaging modalities including ultrasound, computed tomography, magnetic resonance imaging, angiography, and venous sampling. The authors present a case in which CT, MRI, and angiography were negative in attempting to localize the gastrinoma, but In-111 pentetreotide localized the lesion, which was proven surgically.
authors.affiliation: Department of Radiology, Medical University of South Carolina, Charleston 29425, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: McCown
authors.forename: L
authors.initials: L
authors.lastname: Gordon
authors.forename: R P
authors.initials: RP
authors.lastname: Uflacker
mesh_terms: D003937:Diagnosis, Differential; D015408:Gastrinoma / Q000000981:diagnostic imaging*; D006801:Humans; D007205:Indium Radioisotopes; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D013004:Somatostatin / Q000031:analogs & derivatives*; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
chemical_list: D007205:Indium Radioisotopes; D013004:Somatostatin; C081788:pentetreotide